An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2018, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2018-11-30
DOI
10.1155/2018/8087916
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge
- (2018) Alison A. McCormick et al. PLoS One
- Live Attenuated Francisella novicida Vaccine Protects against Francisella tularensis Pulmonary Challenge in Rats and Non-human Primates
- (2014) Ping Chu et al. PLoS Pathogens
- Recent Mechanistic Insights on Glycoconjugate Vaccines and Future Perspectives
- (2013) Francesco Berti et al. ACS Chemical Biology
- Prevention of Staphylococcus aureus Infections by Glycoprotein Vaccines Synthesized in Escherichia coli
- (2013) Michael Wacker et al. JOURNAL OF INFECTIOUS DISEASES
- Identification of a Live Attenuated Vaccine Candidate for Tularemia Prophylaxis
- (2013) Manish Mahawar et al. PLoS One
- A ΔclpB Mutant of Francisella tularensis Subspecies holarctica Strain, FSC200, Is a More Effective Live Vaccine than F. tularensis LVS in a Mouse Respiratory Challenge Model of Tularemia
- (2013) Igor Golovliov et al. PLoS One
- Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis
- (2013) J. Cuccui et al. Open Biology
- Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design
- (2012) V. S. Terra et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Mucosal Immunization with Live Attenuated Francisella novicida U112ΔiglB Protects against Pulmonary F. tularensis SCHU S4 in the Fischer 344 Rat Model
- (2012) Aimee L. Signarovitz et al. PLoS One
- BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: Association of protection with post-vaccination and post-challenge immune responses
- (2012) Susan Twine et al. VACCINE
- Characterization of Monoclonal Antibodies to Terminal and Internal O-Antigen Epitopes of Francisella tularensis Lipopolysaccharide
- (2011) Marly I. Roche et al. HYBRIDOMA
- Antibodies Contribute to Effective Vaccination against Respiratory Infection by Type AFrancisella tularensisStrains
- (2011) Gopi Mara-Koosham et al. INFECTION AND IMMUNITY
- A Francisella tularensis SCHU S4 mutant deficient in -glutamyltransferase activity induces protective immunity: characterization of an attenuated vaccine candidate
- (2011) P. M. Ireland et al. MICROBIOLOGY-SGM
- Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia
- (2011) Anthony J. Hickey et al. VACCINE
- The Fischer 344 Rat Reflects Human Susceptibility to Francisella Pulmonary Challenge and Provides a New Platform for Virulence and Protection Studies
- (2010) Heather J. Ray et al. PLoS One
- Differential susceptibility of Sprague–Dawley and Fischer 344 rats to infection by Francisella tularensis
- (2009) Claudine R. Raymond et al. MICROBIAL PATHOGENESIS
- Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis
- (2009) Qingmei Jia et al. VACCINE
- Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains
- (2009) Terry H. Wu et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search